Safety and efficacy of hepatic vein reconstruction for colorectal liver metastases - 22/09/11
, Junji Yamamoto, M.D. b, Yoshihiro Sakamoto, M.D. c, Rintaro Koga, M.D. a, Makoto Seki, M.D. a, Yoji Kishi, M.D. a
Corresponding author. Tel.: +81-3-3520-0111; fax: +81-3-3570-0343Abstract |
Background |
Colorectal liver metastases with hepatic vein (HV) involvement may require combined resection of the liver and HV. However, the short- and long-term outcomes of such a procedure remain unclear.
Methods |
We reviewed 16 cases of liver resection with major HV resection and reconstruction.
Results |
The patients had a median age of 58.5 years (range, 50–74 y). In total, 18 HVs were reconstructed using a customized great saphenous vein graft (n = 10), direct anastomosis (n = 1), external iliac vein (n = 2), portal vein (n = 1), umbilical vein patch graft (n = 3), or ovarian vein patch graft (n = 1). There was no hospital mortality, and the morbidity rate was 50%. With a median follow-up period of 30 months (range, 4–89 mo), 3 patients died of tumor recurrence and 13 were alive with (n = 6) and without (n = 7) disease. Cumulative 1-, 3-, and 5-year survival rates were 93%, 76%, and 76%, respectively.
Conclusions |
HV resection and reconstruction combined with liver resection can be performed safely with reasonable long-term results.
Le texte complet de cet article est disponible en PDF.Keywords : Hepatic vein reconstruction, Liver resection, Colorectal liver metastases
Plan
Vol 202 - N° 4
P. 449-454 - octobre 2011 Retour au numéro
Article précédent
- Impact of three-dimensional analysis of multidetector row computed tomography cholangioportography in operative planning for hilar cholangiocarcinoma
- Ryoko Sasaki, Tadashi Kondo, Tatsuya Oda, Soichiro Murata, Go Wakabayashi, Nobuhiro Ohkohchi
- Peritoneal computed tomography attenuation values reflect the severity of peritonitis caused by gastrointestinal perforations
- Hironori Tsujimoto, Yoshihisa Yaguchi, Shuichi Hiraki, Naoko Sakamoto, Isao Kumano, Yusuke Matsumoto, Kazumichi Yoshida, Hidekazu Sugasawa, Satoshi Ono, Junji Yamamoto, Kazuo Hase
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?